Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C014211 |
2,3,7,8-tetrachlorodibenzofuran |
2,3,7,8-tetrachlorodibenzofuran affects the expression of YPEL1 mRNA | affects expression | 18343893
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of YPEL1 mRNA | decreases expression | 16788091
|
D001151 |
Arsenic |
Arsenic affects the expression of YPEL1 mRNA | affects expression | 18414638
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of YPEL1 mRNA | decreases expression | 15336504
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YPEL1 mRNA | affects cotreatment|increases expression | 17942748
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of YPEL1 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of YPEL1 mRNA | affects expression | 18343893
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of YPEL1 mRNA | affects cotreatment|increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of YPEL1 mRNA | decreases expression | 16788091
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.59 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.92 | 16251483 18414634 12569548 16835338 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.67 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.67 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.38 | 12928151 19371607 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.76 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.76 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.96 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.71 | 17687452 15504454 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.29 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.29 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
5.00 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
5.00 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.30 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.61 | 17938729 15738583 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.52 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.22 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 17333356 17110522 16919318 15861022 16105132 17681005 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.06 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.05 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.05 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.50 | 9211117 17551590 9142499 10589399 16925845 9125849 9224671 8800419 9664655 14991402 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.99 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.01 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.01 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.23 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.23 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.47 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.43 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.43 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.05 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.66 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.94 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
2,3,7,8-tetrachlorodibenzofuran |
11.95 | 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.95 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.95 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.40 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.68 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.49 | 11953799 9931084 16076760 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.49 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.94 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.42 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.76 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.76 | 15992940 17551590 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.33 | 16930632 12749816 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
8.26 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.26 | 16331271 9834237 17368321 19642359 16823087 17712046 17301526 19035177 17361223 16140955 16766008 17107899 19029980 16788101 19225113 17217047 15748426 19075265 17339181 16935935 17294898 17649720 12679006 17506722 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.36 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.59 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
4.82 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.82 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.48 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.48 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.32 | 14737004 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.20 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.65 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.65 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.51 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.47 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.47 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.92 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.92 | 9142499 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.64 | 17056641 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.21 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.21 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.10 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.53 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.46 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.33 | 15371236 16905509 6392382 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.40 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.40 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
10.16 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
10.16 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.36 | 16283617 16116481 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.80 | 17548696 16353154 15952646 16702368 17453740 16759981 17050553 19834688 17938729 18709164 6392382 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
14.41 | 19538983 16251483 15504454 17029826 17976673 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
14.41 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.41 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
14.41 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.21 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
2.89 | 17976673 11144890 15987713 19429237 17306315 19322015 18640142 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.90 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
5.07 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |